The latest closing stock price for Acrivon Therapeutics as of September 18, 2024 is 7.56.
An investor who bought $1,000 worth of Acrivon Therapeutics stock at the IPO in 2022 would have $-546 today, roughly -1 times their original investment - a -32.60% compound annual growth rate over 2 years.
The all-time high Acrivon Therapeutics stock closing price was 23.20 on February 14, 2023.
The Acrivon Therapeutics 52-week high stock price is 11.90, which is 57.4% above the current share price.
The Acrivon Therapeutics 52-week low stock price is 3.19, which is 57.8% below the current share price.
The average Acrivon Therapeutics stock price for the last 52 weeks is 6.53.
An investor who bought $1,000 worth of Acrivon Therapeutics stock at the IPO in 2022 would have $-546 today, roughly -1 times their original investment - a -32.60% compound annual growth rate over 2 years.
The all-time high Acrivon Therapeutics stock closing price was 23.20 on February 14, 2023.
The Acrivon Therapeutics 52-week high stock price is 11.90, which is 57.4% above the current share price.
The Acrivon Therapeutics 52-week low stock price is 3.19, which is 57.8% below the current share price.
The average Acrivon Therapeutics stock price for the last 52 weeks is 6.53.